News about "Precision Medicine"

Robotics to Transform Every Specialty of Medicine, says Dr. Jitendra Singh

Robotics to Transform Every Specialty of Medicine, says Dr. Jitendra Singh

Dr. Jitendra Singh highlights robotics, AI and nanoscience as key technologies for precision medicine, with applications ranging from robotic surgery to robotic medicine.

Precision Medicine | 03/10/2026 | By News Bureau

Dale Bredesen Proposes Pr2 Theory as New Framework for Understanding Alzheimer's and Neurodegeneration

Dale Bredesen Proposes Pr2 Theory as New Framework for Understanding Alzheimer's and Neurodegeneration

Neuroscientist Dale E. Bredesen has proposed the Pr2 theory, a new framework that views neurodegeneration as a response to persistent biological stress and explores a precision-medicine approach to Alzheimer’s disease.

Precision Medicine | 24/08/2026 | By News Bureau

India Expands AI-Driven Biotechnology Research across Genomics, Healthcare and Biomanufacturing

India Expands AI-Driven Biotechnology Research across Genomics, Healthcare and Biomanufacturing

The Government of India is advancing AI-driven biotechnology through GenomeIndia, Bio-AI Hubs, IBDC and medical imaging initiatives to boost precision medicine and healthcare.

Precision Medicine | 31/07/2026 | By News Bureau |  207

IMU Biosciences Partners with Waters to Advance AI Immune Mapping Platform

IMU Biosciences Partners with Waters to Advance AI Immune Mapping Platform

IMU Biosciences has selected Waters to advance its Artificial Intelligence (AI)-powered immune mapping platform, accelerating early disease diagnosis, patient monitoring, and precision medicine development.

Precision Medicine | 26/06/2026 | By News Bureau |  282

Sophia Genetics Signs MoU with Memorial Sloan Kettering Cancer Center

Sophia Genetics Signs MoU with Memorial Sloan Kettering Cancer Center

Sophia Genetics has signed a strategic collaboration Memorandum of Understanding (MoU) with Memorial Sloan Kettering Cancer Center to establish a next-generation precision medicine hub.

Precision Medicine | 08/06/2026 | By News Bureau |  217

Tempus Wins FDA Approval for xT CDx, Expanding Solid Tumor Testing Portfolio

Tempus Wins FDA Approval for xT CDx, Expanding Solid Tumor Testing Portfolio

Tempus has received US FDA approval for its tumor-only xT CDx, becoming the first laboratory with companion diagnostic approval for both tumor-only and tumor-normal genomic profiling.

Precision Medicine | 30/05/2026 | By News Bureau |  340

Genethon and Ampersand Biomedicines Partner to Develop Precision Gene Therapy Vectors

Genethon and Ampersand Biomedicines Partner to Develop Precision Gene Therapy Vectors

Genethon and Ampersand Biomedicines join forces to engineer advanced AAV gene therapy vectors designed for greater tissue specificity, potentially enabling safer and more effective treatments for patients with rare genetic disorders.

Precision Medicine | 25/05/2026 | By News Bureau |  157

Dr. Jitendra Singh Launches UMMID Program, Highlights Future of Genomic and Precision Medicine

Dr. Jitendra Singh Launches UMMID Program, Highlights Future of Genomic and Precision Medicine

Dr. Jitendra Singh dedicates the UMMID Program to the nation, highlighting the growing role of genomic and precision medicine in advancing early intervention, personalised treatment, and affordable healthcare for rare genetic disorders in India.

Precision Medicine | 22/05/2026 | By News Bureau |  226

Thryv Therapeutics Advances THRV-1268 Programme with Phase II/III Trial and FDA Fast Track Status

Thryv Therapeutics Advances THRV-1268 Programme with Phase II/III Trial and FDA Fast Track Status

Thryv Therapeutics initiates Phase II/III clinical testing and secures FDA Fast Track status for THRV-1268, advancing a potential first-in-class therapy for Long QT Syndrome.

Precision Medicine | 27/04/2026 | By News Bureau |  220

GlycoNex Secures PMDA Nod for First-in-Human Trial of Cancer Drug GNX1021

GlycoNex Secures PMDA Nod for First-in-Human Trial of Cancer Drug GNX1021

Japan’s Pharmaceuticals and Medical Devices Agency approves Phase I clinical trial of GlycoNex’s novel antibody-drug conjugate targeting gastrointestinal cancers.

Precision Medicine | 16/04/2026 | By News Bureau |  372


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members